Rocket Pharmaceuticals raises ~$182.8M in public offering and private placement

ROCKET PHARMACEUTICALS, INC.

Public offering of 15.18M shares at $12.50/sh, including full exercise of underwriters' option; net proceeds ~$178.1M.
Private placement of 400,000 pre-funded warrants at $12.49 to RTW Innovation Master Fund, net proceeds ~$4.7M.
Proceeds to fund pipeline development, commercialization preparedness, and general corporate purposes.
45-day lock-up on sales of common stock by officers, directors, and certain shareholders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.